Healthcare & Life Sciences
Probiodrug
Germany
About
Probiodrug is a biotechnology company developing therapeutic agents for Alzheimer's disease by inhibiting glutaminyl cyclase to prevent the formation of pyroglutamate-modified amyloid-beta, with their lead program historically known as PQ912 or varoglutamstat.
Explore Probiodrug's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.